Rescentris Named 2007 Bio-IT World Conference Best of Show Finalist

Columbus, Ohio – April 27, 2007 - Rescentris, the leading provider of electronic lab notebook (ELN) software for the life sciences industry, today announced that its award winning Collaborative Electronic Research Framework™ (CERF) lab notebook software has been named a finalist for the 2007 Bio-IT World Conference & Expo Best of Show Awards. Judged by a team of Bio-IT World Magazine editors and leading industry experts, the awards program spotlights new products demonstrating exceptional technology innovation across the life sciences research, discovery and clinical trials process. Finalists were chosen based on the products’ technical merit, functionality and innovation.

“We are thrilled to be among 12 distinguished finalists and the only electronic lab notebook software product nominated,” noted Adel Mikhail, CEO of Rescentris. “I am proud of our entire team - it was their efforts and constant drive to deliver our new CERF 2.6 release that made this recognition possible.”

Executive Editor of Bio-IT World John Russell will present the awards in each category at the ceremony May 1, from 6:15 to 7:15 pm on the show floor at the Bio-IT World Conference & Expo at the World Trade Center in Boston, Massachusetts. For complete coverage of the awards, visit www.Bio-ITWorldExpo.com.

About Rescentris
Rescentris provides electronic laboratory notebook and scientific content management software solutions that enable R&D organizations to create, organize, share, and exploit their knowledge assets. Its product, CERF, provides a unified desktop for knowledge workers and delivers R&D performance improvements for stakeholders throughout life sciences research organizations. See www.rescentris.com for more information.

About Bio-IT World
Bio-IT World publishes critical information across a variety of media to meet the needs of bio-IT professionals. Coverage focuses on the range of tools and techniques, both computational and experimental, that increase the efficiency and success of drug discovery, development, and clinical trials. See www.Bio-ITWorld.com.

Contact:
Christy Newland, Rescentris Public Relations
502-418-6757